Xenon Pharmaceuticals (XENE) Change in Receivables (2013 - 2025)
Xenon Pharmaceuticals' (XENE) quarterly Change in Receivables came in at $7.2 million in Q1 2025, up 18989.47% year-on-year from N/an in Q1 2024, and up 1212.25% on a QoQ basis from $547000.0 in Q4 2024.
Xenon Pharmaceuticals (XENE) Change in Receivables (2013 - 2025) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 13 years of Change in Receivables data on file, last reported at $7.2 million in Q1 2025.
- On a quarterly basis, Change in Receivables rose 18989.47% year-over-year to $7.2 million in Q1 2025; TTM through Mar 2025 was $7.8 million, a 13400.0% increase from a year earlier, with the FY2024 full-year figure at $614000.0, up 572.31% from the prior year.
- Change in Receivables for Q1 2025 stood at $7.2 million, up from $547000.0 in the prior quarter.
- Over the last five years, Change in Receivables for XENE reached as high as $7.2 million in Q1 2025 and fell as low as -$2.6 million in Q2 2021.
- Historically, Change in Receivables has averaged $374352.9 across 5 years, with a median of -$7000.0 in 2022.
- Across the five-year window, Change in Receivables plunged 2114.29% in 2023 and jumped 18989.47% in 2025, its largest moves.
- Year by year, Change in Receivables stood at -$481000.0 in 2021, then slumped by 214.97% to -$1.5 million in 2022, then surged by 119.41% to $294000.0 in 2023, then jumped by 86.05% to $547000.0 in 2024, then soared by 1212.25% to $7.2 million in 2025.
- Per Business Quant data, the three most recent Change in Receivables figures were $7.2 million in Q1 2025, $547000.0 in Q4 2024, and $83000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 7.18 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Dec 31, 2024 | 547,000.00 |
| Dec 31, 2024 | 547,000.00 |
| Sep 30, 2024 | 83,000.00 |
| Sep 30, 2024 | 83,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 294,000.00 |
| Dec 31, 2023 | 294,000.00 |
| Sep 30, 2023 | -155,000.00 |
| Sep 30, 2023 | -155,000.00 |
| Jun 30, 2023 | -43,000.00 |
| Jun 30, 2023 | -43,000.00 |
| Mar 31, 2023 | -226,000.00 |
| Mar 31, 2023 | -226,000.00 |
| Dec 31, 2022 | -1.52 Mn |
| Dec 31, 2022 | -1.52 Mn |